Search

everythinglearnresearchcommunity

for

Search:↓

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

More research needed to confirm finasteride as standard treatment for FFA.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Fetuin A, Anigozanthos Flavidus extract, and Ovol2 affect wound healing and skin regeneration.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Mushroom-based scaffolds help heal skin wounds and regrow hair.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Topical tofacitinib shows promise as a future treatment for alopecia areata.